Comprehensive Study on Point-Of-Care Testing (POCT) Market In-Depth Analysis of Top Impacting Factors with Key Players: Biomerica, Atlas Genetics, Accriva Diagnostics, Beckman Coulter, BD, Johnson & Johnson, Alere, PTS Diagnostics, Abbott, Siemens, Roche,

New Report on “Global Point-of-Care Testing Market” added to databridgemarketresearch.com database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

This report by DBMR research brings to you all the businesses profiles required to be within the competition for the worldwide Point-of-Care Testing Market. With the assistance of SWOT analysis the report tells you regarding all the market restrain and drivers to be followed within the forecast amount of 2018-2025 whereas additionally explaining what the Point-of-Care Testing Market definition, classifications, applications, and engagements square measure and providing with all the figures of CAGR levels within the historic year 2016, base year 2017 and forecast year 2018-2025.

Global Point-of-Care Testing (POCT) Market Analysis By Product, Prescription Mode, Distribution Channel, End User, Geography- Trends and Forecast to 2024

Request for sample copy of this report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=point-care-testing-poct-market

HOFFMANN-LA ROCHE LTD:

Historical Background – Roche was established in 1896

Nature of Business: F. Hoffmann-La Roche Ltd., is one of the largest biotech company with 17 biopharmaceuticals on the market. The company is operating in more than 100 countries around the globe. Some of the subsidiaries are Genetech, Roche Diagnostics, Chugai Pharmaceutical Co., Ventana Medical Systems, InterMune, Inc., Syntex, Anadys Pharmaceuticals, Roche Applied Science, Bioveris, Roche products, Inc., Roche pharma AG, Pt Roche Indonesia, Bina Technologies, Inc., nv Roche sa, Roche SAS, Roche Glycart AG, Roche Co., Ltd.

Main focus: Since the establishment in 1896, the company’s main focus is on oncology, immunology, ophthalmology, infectious diseases and neuroscience.

Main Business Areas: Pharmaceuticals and Diagnostics.

Recent Developments:

1. In August 2016,Roche Diagnostics Ltd., received FDA approval for cobas Influenza A/B & RSV test for the cobasLiat System that differentiates flu and Respiratory Syncytial Virus (RSV) in 20 minutes

2. In May 2015, Roche Diagnostics Ltd., received FDA CLIA Waiver for the cobasLiat PCR System and Strep A assay to test Strep A in throat swab specimen.

3. In December 2014, Roche Diagnostics Ltd, received FDA approval for LightMix Ebola Zaire rRT-PCR Test at the time of emergency to treat Ebola Zaire virus infection.

SIEMENS AG:

Historical Background: Siemens AG was established in 1847

Nature of business: Siemens AG is a German leading company specializing in supplier of systems for power generation and transmission, medical diagnosis, infrastructure and industry solutions.

Main focus: Since the establishment in 1847, the company’s main focus is on electrification, automation and digitalization
Main Business areas: power and gas, wind power and renewable, energy management, building technologies, mobility, digital factory and process industries.

Recent Developments:

1. In November 2016, Siemens strengthened its healthcare business through public listing to give more focus and flexibility in pursuing its growth strategy.

2. In June 2016, Siemens opened a new headquarter in Munich to enhance its global presence in this market.

ABBOTT:

Historical Background: Abbott was established in 1888.

Nature of business: Abbott is a globally diversified healthcare company focused on development and marketing of diagnostics products, medical devices, nutrition and branded generic pharmaceuticals.

Main focus: Since the establishment in 1888, the company’s main focus is on established pharmaceutical, molecular diagnostics, diabetes care and nutritionals.

Main Business areas: Established pharmaceuticals, molecular diagnostics, diabetes care nutritionals, and vascular.

Recent Developments:

1. In May 2017, Abbott announced CE Mark approval and its use of the new Rx Insertable Cardiac Monitor (ICM), which is the world’s first smartphone compatible ICM to identify or detect cardiac arrhythmias, including atrial fibrillation (AF), for therapy.

2. In May 2017, Abbott announced the national reimbursement for freestyle Libre in France, providing access to revolutionary technology for people suffering with diabetes. This would help thousands of people to have access to test type 1 and type 2 diabetes.

3. In February 2017, FDA granted the use of Abbott Real Time Zika test product to detect Zika virus in whole blood samples for use of in vitro diagnostic tests during emergencies.

Any specific requirements are you looking for? Ask to your Industry Experts @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=point-care-testing-poct-market

TABLE OF CONTENTS GLOBAL POINT-OF-CARE TESTING MARKET

1. INTRODUCTION

2. MARKET SEGMENTATION

3. MARKET OVERVIEW

3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL POINT-OF-CARE TESTING MARKET: REGULATORY SCENARIO

7. GLOBAL POINT-OF-CARE TESTING MARKET: REIMBURSEMENT SCENARIO

8. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE

8.1. OVERVIEW

8.2. CARDIOMETABOLIC MONITORING KITS
8.2.1. CARDIAC MARKERS
8.2.2. BLOOD GAS ELECTROLYTE TESTING KITS
8.2.3. HBA1C TESTING KITS
8.2.4. LIPID TESTING KITS

8.3. INFECTIOUS DISEASE TESTING KITS
8.3.1. INFLUENZA TESTING KITS
8.3.2. HIV TESTING KITS
8.3.3. HEPATITIS TESTING KITS
8.3.4. STD TESTING KITS
8.3.5. TROPICAL DISEASESTESTING KITS
8.3.6. HEALTHCARE ASSOCIATED TESTING KITS
8.3.7. RESPIRATORY INFECTIONS TESTING KITS

8.4. CHOLESTEROL TESTING KITS
8.4.1. PROTHROMBIN TIME TESTING KITS
8.4.2. ACTIVATED CLOTTING TIME TESTING KITS

8.5. BLOOD GLUCOSE TESTING KITS

8.6. PREGNANCY AND FERTILITY TESTING KITS

8.7. TUMOR CANCER MARKERS

8.8. URINALYSIS TESTING KITS

8.9. HEMATOLOGY TESTING KITS

8.10. DRUGS OF ABUSE TESTING KITS

8.11. FECAL OCCULT TESTING KITS

8.12. RAPID COAGULATION TESTING KITS

9. GLOBAL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL

9.1. OVERVIEW
9.1.1. DIRECT TENDER
9.1.2. RETAIL PHARMACY

10. GLOBAL POINT-OF-CARE TESTING MARKET, BY END USER

10.1. OVERVIEW
10.2. GLOBAL POCT MARKET: HOSPITALS
10.3. GLOBAL POCT MARKET: CLINICS
10.4. GLOBAL POCT MARKET: AMBULATORY CARE
10.5. GLOBAL POCT MARKET: HOME HEALTHCARE
10.6. GLOBAL POCT MARKET: RESEARCH LABORATORIES

11. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE

11.1. OVERVIEW
11.2. GLOBAL POCT MARKET: PRESCRIPTION BASED TESTING KITS
11.3. GLOBAL POCT MARKET: OVER THE COUNTER BASED TESTING KITS

12. GLOBAL POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY
12.1. OVERVIEW
12.2. NORTH AMERICA POINT-OF-CARE TESTING MARKET
12.3. EUROPE POINT-OF-CARE TESTING MARKET
12.4. APAC POINT-OF-CARE TESTING MARKET
12.5. MEA POINT-OF-CARE TESTING MARKET
12.6. SOUTH AMERICA POINT-OF-CARE TESTING MARKET

13. GLOBAL POINT-OF-CARE TESTING MARKET: COMPANY LANDSCAPE

14. COMPANY PROFILES
14.1. JOHNSON AND JOHNSON SERVICES, INC.
14.2. BECTON, DICKINSON AND COMPANY
14.3. MEDTRONIC
14.4. F. HOFFMANN-LA ROCHE LTD
14.5. SIEMENS AG
14.6. ABBOTT
14.7. DANAHER
14.8. WERFENLIFE

15. RELATED REPORTS

Browse Detailed TOC, Tables and Figures @ http://databridgemarketresearch.com/toc/?dbmr=point-care-testing-poct-market

Related Report

Europe POCT Device Market – Trends and Forecast To 2024

Europe Point-of-care Testing (POCT) Market, By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits), Prescription Mode (Prescription, OTC), Distribution Channel, End User, Country – Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/europe-poct-device-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.